Lates News

English Silicon Intelligence announced on the Hong Kong Stock Exchange that the company has reached a strategic cooperation agreement with Takeda Pharmaceuticals. Leveraging the end-to-end Pharma.AI platform independently developed by English Silicon Intelligence, the two companies will jointly promote the research and development of candidate drugs in the disease treatment area selected by Takeda Pharmaceuticals. The aim is to discover candidate drugs targeting high-potential treatment targets with clinical differentiation advantages.